Stock Events

NLS Pharmaceutics 

$0.05
0
+$0+0% Tuesday 20:49

Statistics

Day High
0.05
Day Low
0.04
52W High
0.18
52W Low
0.04
Volume
119,605
Avg. Volume
11,008
Mkt Cap
8.03M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

11OctConfirmed
Q4 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q3 2022
-1
-0.67
-0.33
0
Expected EPS
0
Actual EPS
-0.54

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NLSPW. It's not an investment recommendation.

About

Health Technology
Pharmaceuticals: Major
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
Show more...
CEO
Employees
6
Country
CH
ISIN
CH0573155204

Listings